Viewing Study NCT07011732


Ignite Creation Date: 2025-12-24 @ 9:29 PM
Ignite Modification Date: 2025-12-28 @ 3:20 PM
Study NCT ID: NCT07011732
Status: RECRUITING
Last Update Posted: 2025-12-16
First Post: 2025-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module